Alfa Wassermann

What Alfa Wassermann does

Alfa Wassermann is a privately held US medical device and bioprocess equipment manufacturer founded in 1970 and headquartered at 4 Henderson Drive, West Caldwell, New Jersey, with 51-100 employees. The company operates through two distinct divisions: Alfa Wassermann Diagnostic Technologies (AWDT), which manufactures and sells clinical chemistry analyzers (ACE Axcel for physician practices and small hospitals, Vet Axcel for veterinary offices, and an ACE Axcel variant for biopharmaceutical research) along with associated reagents, consumables, and service plans; and Alfa Wassermann Separation Technologies (AWST), which supplies continuous flow ultracentrifuges and fluid management systems used in the development, purification, and manufacturing of vaccines, gene therapies, and other bio-products. AWST's product line positions the company as a global supplier to the biopharmaceutical manufacturing value chain.

The business model combines one-time hardware sales with a recurring consumables and reagents stream tied to the installed base of analyzers, supplemented by multi-tier service plan offerings and PACE-accredited operator training included with system purchase. Distribution is executed exclusively through authorized US distributors — notably Medline since September 2015 — supported by a nationwide network of company-trained engineers, certified Medical Technologists, and Hardware Specialists providing 24/7 technical support. The company has received the NorthFace Scoreboard Award for Excellence in Customer Satisfaction for over 20 consecutive years, underscoring a customer-service-led positioning within the niche physician-office laboratory (POL) segment.

Alfa Wassermann's primary customer segments are physician office laboratories and small hospitals (in-office diagnostic testing for disease diagnosis, treatment, and monitoring), veterinary practices (companion animal diagnostics), and biopharmaceutical companies (research applications and vaccine/gene-therapy manufacturing support through AWST). There is no disclosed revenue, no public listing, no disclosed institutional ownership, and no disclosed AI/ML capability; the company appears as a stable, privately controlled, multi-decade operator in a mature diagnostic-instrumentation niche.

Name

Alfa Wassermann

Legal name

Alfa Wassermann Diagnostic Technologies, LLC

Website

https://awdt.us

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Clinical Chemistry Analyzers

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Clinical chemistry analyzers
• Veterinary diagnostic equipment
• Continuous flow ultracentrifuges
• Biopharmaceutical separation systems
• In-office diagnostic testing

Headquarters

HQ city

West Caldwell

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Clinical Chemistry Analyzers: Sale of clinical chemistry analyzer instruments and systems to physician offices, veterinary offices, and biopharmaceutical companies.
2. Reagents and Consumables: Ongoing sales of reagents and lab supplies required to run Alfa Wassermann chemistry analyzers, providing recurring revenue from the installed base.
3. Service Plans: Various service plan options available for customers to maintain and support their Alfa Wassermann chemistry systems.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Alfa Wassermann designs, manufactures, and supports clinical chemistry analyzers and reagents (ACE Axcel, Vet Axcel product lines) for physician offices, small hospitals, veterinary practices, and biopharmaceutical research. Through its Separation Technologies (AWST) division, it also manufactures continuous flow ultracentrifuges and fluid management systems used in the development, purification, and manufacturing of vaccines, gene therapies, and other bio-products. The company sells its instruments and consumables via authorized distributors and provides 24/7 technical support through a nationwide network of company-trained engineers.

Product overview

Alfa Wassermann operates two main divisions: Alfa Wassermann Diagnostic Technologies (AWDT) and Alfa Wassermann Separation Technologies (AWST). AWDT offers clinical chemistry analyzers and reagents through its ACE Axcel and Vet Axcel product lines, serving physician practices/small hospitals, veterinary offices, and biopharmaceutical research. AWST provides continuous flow ultracentrifuges and fluid management systems for vaccine development, gene therapy manufacturing, and bio-product purification. The company has over 50 years of manufacturing and service excellence with a nationwide network of company-trained engineers.

Differentiator

Problem solved

Functional benefit

Brands

• ACE Axcel: Clinical chemistry system for physician practices and small hospitals.
• Vet Axcel

Products and services

• ACE Axcel Clinical Chemistry System Clinical chemistry analyzer system designed for physician practices and small hospitals, providing reliable and accurate in-office diagnostic testing capabilities for disease diagnosis, treatment, and monitoring.
• Vet Axcel Veterinary clinical chemistry analyzer designed for animal health diagnostics, enabling veterinarians to perform in-clinic blood chemistry testing for companion animals.
• Vet Axcel for BioPharma Research Chemistry analyzer system adapted for biopharmaceutical research applications, supporting drug development and validation testing workflows.
• COVID-19 Reagent Panel Reagent panel designed for use with Alfa Wassermann chemistry analyzers to detect COVID-19 antibodies in patient samples.
• Alfa Wassermann Separation Technologies (AWST) Systems Continuous flow ultracentrifuges and fluid management systems used in the development, purification and manufacturing of vaccines, gene therapies, and other bio-products.

Quantifiable outcome

• 24/7 technical support coverage, 365 days a year
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• MedlinecoreChannel Partner/ Reseller/ Distributor · 1 September 2015Alfa Wassermann Diagnostic Technologies became a new supplier to Medline in September 2015, expanding distribution channels for their clinical chemistry products through Medline's extensive healthcare distribution network.

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Cytiva: Broad incumbent in bioprocessing. Cytiva (formerly GE Healthcare Life Sciences) supplies separation, purification, and fluid management systems into vaccine and gene therapy manufacturing — directly adjacent to AWST's continuous-flow ultracentrifuge offering.
• Siemens Healthineers: Broad incumbent in clinical chemistry. Siemens' Atellica and ADVIA Centaur systems serve the same hospital/POL chemistry testing market, with broader test menus and global service infrastructure that small-scale competitors struggle to match.
• Alfa Laval: Broad incumbent in industrial separation technology. Alfa Laval's separation and fluid handling equipment competes with AWST in bioprocessing and bio-product manufacturing applications, particularly in larger-scale vaccine and pharma production.
• Roche Diagnostics: Broad incumbent in clinical chemistry. Roche's cobas c-series and compact analyzers serve the same physician office and small hospital segment that ACE Axcel addresses, with substantially broader menu and global reach.
• Abbott Diagnostics: Broad incumbent in clinical chemistry. Abbott's Architect and Alinity ci-series platforms compete for hospital and reference lab chemistry testing share adjacent to Alfa Wassermann's small-hospital and POL segment.

Direct peers

• Beckman Coulter (Danaher): Direct peer across both divisions: Beckman Coulter manufactures clinical chemistry analyzers that compete head-to-head with ACE Axcel in physician office and small hospital labs, and is also a leading manufacturer of preparative ultracentrifuges that overlap directly with AWST's continuous-flow separation products.
• IDEXX Laboratories: Direct competitor in the veterinary in-clinic diagnostics space. IDEXX's Catalyst One / Catalyst Dx analyzers compete with Vet Axcel for the same companion animal practice customers and offer similar chemistry panel workflows.
• Abaxis (Zoetis): Direct peer in the veterinary in-clinic chemistry analyzer market. Abaxis (acquired by Zoetis) sells the VetScan series — purpose-built benchtop chemistry analyzers for companion animal practices that compete head-to-head with the Vet Axcel platform.
• Heska (Mars Petcare / Antech Diagnostics): Direct peer in veterinary point-of-care diagnostics. Heska's chemistry systems, now integrated into Antech Diagnostics within Mars Petcare, compete directly with Vet Axcel for veterinary practice chemistry testing share.

Emerging players

• QuidelOrtho: Emerging peer in clinical chemistry and immunoassay. QuidelOrtho's Vitros systems (inherited from Ortho Clinical Diagnostics) target hospital and POL chemistry workloads, competing with ACE Axcel at the smaller end of the customer spectrum.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alfa-wassermann-diagnostic-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alfa Wassermann